Thirty-Day Mortality After Nephrectomy: Clinical Implications for Informed Consent

European Urology

Volumn 56, Issue 6, 2009, Pages 998-1005

  Cloutier, Vincent ^a,b   Capitanio, Umberto ^a,c   Zini, Laurent ^a,d   Perrotte, Paul ^b   Jeldres, Claudio ^a,b   Shariat, Shahrokh F ^a   Arjane, Philippe ^b   Patard, Jean Jacques ^e   Montorsi, Francesco ^c   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

Author keywords

30 day mortality; Nephrectomy; Surgical mortality

Indexed keywords

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HUMAN; INFORMED CONSENT; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INFORMED CONSENT; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEPHRECTOMY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEER PROGRAM; TIME FACTORS;

EID: 70350567329     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.11.023     Document Type: Article

References (30)

1. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
2. Karakiewicz P.I., Trinh Q.-D., Bhojani N., et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 51 (2007) 1616-1624
3. Margulis V., Tamboli P., Jacobsohn K.M., Swanson D.A., and Wood C.G. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 100 (2007) 1235-1239
4. Karakiewicz P.I., Briganti A., Chun F.K., et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25 (2007) 1316-1322
5. Mejean A., Vogt B., Quazza J.E., Chretien Y., and Dufour B. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol 36 (1999) 298-302
6. Beisland C., Medby P.C., Sander S., and Beisland H.O. Nephrectomy-indications, complications and postoperative mortality in 646 consecutive patients. Eur Urol 37 (2000) 58-64
7. Swanson D.A., and Borges P.M. Complications of transabdominal radical nephrectomy for renal cell carcinoma. J Urol 129 (1983) 704-707
8. Karakiewicz P.I., and Hutterer G.C. Predicting cancer-control outcomes in patients with renal cell carcinoma. Curr Opin Urol 17 (2007) 295-302
9. Karakiewicz P.I., Trinh Q.D., de la Taille A., et al. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. Eur J Cancer 43 (2007) 1023-1029
10. Karakiewicz P.I., Lewinshtein D.J., Chun F.K.-H., et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 50 (2006) 521-529 discussion 529
11. Walz J., Suardi N., Shariat S.F., et al. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU Int 102 (2008) 33-38
12. Gallina A., Suardi N., Montorsi F., et al. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men. Int J Cancer 123 (2008) 647-652
13. Zini L, Perrotte P, Jeldres C, et al. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma. BJU Int. 2008 Aug 14. [Epub ahead of print].
14. Lesage K., Joniau S., Fransis K., and Van Poppel H. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol 51 (2007) 614-620
15. Ciancio G., Livingstone A.S., and Soloway M. Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 51 (2007) 988-995 discussion 994-5
16. Van Poppel H., Da Pozzo L., Albrecht W., et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51 (2007) 1606-1615
17. Karakiewicz P.I., Suardi N., Capitanio U., et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 55 (2009) 287-295
18. Capitanio U., Jeldres C., Shariat S.F., and Karakiewicz P. Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. Eur Urol 54 (2008) 958-959
19. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer statistics review, 1975-2004. http://seer.cancer.gov/csr/1975-2004. Accessed January 2007.
20. Harrell Jr. F.E., Califf R.M., Pryor D.B., Lee K.L., and Rosati R.A. Evaluating the yield of medical tests. JAMA 247 (1982) 2543-2546
21. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
22. Thoroddsen A., Gudbjartsson T., Jonsson E., Gislason T., and Einarsson G.V. Operative mortality after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol 37 (2003) 507-511
23. Corman J.M., Penson D.F., Hur K., et al. Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program. BJU Int 86 (2000) 782-789
24. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
25. Walz J., Montorsi F., Jeldres C., et al. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases. BJU Int 101 (2008) 826-832
26. Yeo K.K., Li Z., and Amsterdam E. Clinical characteristics and 30-day mortality among Caucasians, Hispanics, Asians, and African-Americans in the 2003 California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol 100 (2007) 59-63
27. Manoukian S.V., Feit F., Mehran R., et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49 (2007) 1362-1368
28. Krumholz H.M., Wang Y., Mattera J.A., et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 113 (2006) 1683-1692
29. Carandang R., Seshadri S., Beiser A., et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296 (2006) 2939-2946
30. Gilbert S.M., Dunn R.L., Miller D.C., et al. Mortality after urologic cancer surgery: impact of non-index case volume. Urology 71 (2008) 906-910